Bottom line
MEDI vs XLV: the short answer
MEDI (Harbor Health Care ETF) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both etfs.
XLV is cheaper at 0.08% vs 0.8% — a difference of $72 a year per $10,000 invested.
Over one year, MEDI returned +27.1% vs +14.5% for XLV.
Updated Nov 19, 2026
MEDI vs XLV side by side
| MEDI | XLV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Oakmark (Harris) | SPDR (State Street) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.8% | 0.08% |
| Annual cost per $10k | $80 | $8 |
| 10-yr cost on $10k (prospectus) | $990 | $103 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0.02% |
| 1-yr return | +27.1% | +14.5% |
| 5-yr return (annualized) | — | +8.1% |
| 10-yr return (annualized) | — | +9.8% |
| Best quarter | +14.4% | +14.5% |
| Worst quarter | −10.9% | −12.7% |
| Net assets (fund) | $41.2M | $40.6B |
| Number of holdings | 44 | 65 |
| Portfolio turnover | 167% | 2% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | MEDI | XLV | Difference |
|---|---|---|---|
| 2025 | +27.1% | +14.5% | +12.6% |
| 2024 | +0.5% | +2.5% | −2.0% |
| 2023 | +24.8% | +2.0% | +22.8% |
Source: Fund prospectus bar charts
Holdings overlap
11 of MEDI's top 25 holdings also appear in XLV's top 25.
| Holding | MEDI | XLV |
|---|---|---|
| Eli Lilly & Co | 20.78% | 16.51% |
| Gilead Sciences Inc | 5.10% | 2.73% |
| AbbVie Inc | 3.09% | 7.74% |
| Intuitive Surgical Inc | 2.83% | 2.45% |
| Cencora Inc | 2.75% | 0.96% |
| Merck & Co Inc | 2.47% | 5.52% |
| Boston Scientific Corp | 2.40% | 1.10% |
| McKesson Corp | 2.02% | 1.58% |
| Danaher Corp | 1.73% | 2.09% |
| UnitedHealth Group Inc | 1.39% | 6.57% |
| Vertex Pharmaceuticals Inc | 1.22% | 2.19% |
Source: SEC Form N-PORT
MEDI top 10
- Eli Lilly & Co — 20.78%
- Ascendis Pharma A/S — 13.61%
- Gilead Sciences Inc — 5.10%
- Rhythm Pharmaceuticals Inc — 4.02%
- AbbVie Inc — 3.09%
- Intuitive Surgical Inc — 2.83%
- Cencora Inc — 2.75%
- Revolution Medicines Inc — 2.54%
- Insmed Inc — 2.52%
- Merck & Co Inc — 2.47%
XLV top 10
- Eli Lilly & Co — 16.51%
- Johnson & Johnson — 10.64%
- AbbVie Inc — 7.74%
- UnitedHealth Group Inc — 6.57%
- Merck & Co Inc — 5.52%
- Amgen Inc — 3.40%
- Thermo Fisher Scientific Inc — 3.24%
- Abbott Laboratories — 2.75%
- Gilead Sciences Inc — 2.73%
- Intuitive Surgical Inc — 2.45%
FAQ
What is the difference between MEDI and XLV?
Which is cheaper, MEDI or XLV?
Should I own both MEDI and XLV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.